News
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Le Groupe Talis annonce avoir signé des accords pour acquérir Aston
Le Groupe Talis acquiert Aston, école spécialisée en cybersécurité, renforçant son réseau d'écoles post bac et de formations professionnalisantes. Alliances stratégiques pour l'insertion professionnelle des étudiants -
-
-
COMMUNIQUÉ DE PRESSE
ProCredit group reaches key milestones in its comprehensive sustainability strategy in 2023 and defines further targets
ProCredit group achieves key sustainability milestones in 2023, including the opening of 'ProEnergy' solar park in Kosovo and development of Gender Action Plan. Full Impact Report available on ProCredit Holding website -
COMMUNIQUÉ DE PRESSE
ZEAL achieves double-digit growth in 2023 and raises earnings to a five-year high
ZEAL Network SE achieves double-digit growth in 2023, with billings and revenue up by 11% and 10%, respectively. EBITDA reaches a five-year high at €32.9 million. Company expands market share to 41.4% -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: ZEAL Network SE acquires further shares in Lotto24 AG and announces intention to request the squeeze-out of the minority shareholders of Lotto24 AG
ZEAL Network SE acquires more shares in Lotto24 AG and plans to squeeze out minority shareholders. The company aims to reach 95% ownership and initiate the squeeze-out process -
COMMUNIQUÉ DE PRESSE
ENCAVIS remains on its growth trajectory in Germany, significantly enhancing its energy production capacity with the construction of its 114-megawatt solar park in Borrentin
Encavis AG collaborates with BELECTRIC to construct a 114-megawatt solar park in Borrentin, enhancing energy production capacity. The project marks a significant step towards the company's ambitious 7 GW generation capacity goal in Europe by 2027 -
COMMUNIQUÉ DE PRESSE
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche
Lonza Group AG signs agreement to acquire Genentech manufacturing facility in Vacaville (US) from Roche for USD 1.2 billion. Acquisition aims to expand large-scale biologics manufacturing capacity, enhance capabilities, and update sales growth guidance
